Literature DB >> 15474281

The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines.

Antoine G van der Heijden1, Cornelius F J Jansen, Gerald Verhaegh, Michael A O'donnell, Jack A Schalken, J Alfred Witjes.   

Abstract

INTRODUCTION: Hyperthermia and mitomycin-C (MMC) have given very encouraging results in several clinical studies for the treatment of superficial transitional cell carcinoma of the bladder. However, a synergistic effect of hyperthermia and MMC on the decrease of cell proliferation has never been demonstrated accurately in vitro. We investigated the effect of MMC versus MMC combined with hyperthermia on the cytotoxicity in four human bladder cancer cell lines.
MATERIAL AND METHODS: The RT112, RT4, 253J and T24 human bladder cancer cell lines were seeded in 96-well microtiter plates at 2.0 x 10(4) cells per well and were left to attach for 24 hours. The cells were then treated for 60 minutes with MMC concentrations ranging from 0 to 400 microg/ml at a temperature of 37 degrees C or 43 degrees C. After treatment cells were rinsed three times with culture medium and left for 24 hours in the incubator. Dimethyl thiazolyl tetrazolium (MTT) solution was added and after 4 hours of incubation the MTT containing media was aspired from all wells and 100 microl of dimethyl sulfoxide was added to each well. A spectrum analyses was performed at 595 nm light wavelength.
RESULTS: A decrease of cell proliferation after treatment with increasing concentrations MMC was demonstrated. Hyperthermia has a synergistic effect on the decrease of cell proliferation by different concentrations MMC. In the cells treated without MMC no significant difference in the extent of cell killing at 37 degrees C and 43 degrees C was observed. Furthermore, no difference was observed between cells with a p53 protein mutation (RT112 and T24) or without a p53 protein mutation (253J and RT4).
CONCLUSION: A clear synergistic effect of MMC and hyperthermia has been demonstrated in four human bladder cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474281     DOI: 10.1016/j.eururo.2004.06.009

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  13 in total

Review 1.  Adjuvant methods to improve results of local bladder irrigations by chemotherapy for NMIBC.

Authors:  Yuval Freifeld; Yoram Dekel; Avi Stein
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

Review 2.  A systematic review of regional hyperthermia therapy in bladder cancer.

Authors:  Thomas A Longo; Ajay Gopalakrishna; Matvey Tsivian; Megan Van Noord; Coen R Rasch; Brant A Inman; Elisabeth D Geijsen
Journal:  Int J Hyperthermia       Date:  2016-05-01       Impact factor: 3.914

Review 3.  The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer.

Authors:  S E Slater; P Patel; R Viney; M Foster; E Porfiri; N D James; B Montgomery; R T Bryan
Journal:  Ann R Coll Surg Engl       Date:  2014-09       Impact factor: 1.891

4.  GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis.

Authors:  Taku Naiki; Aya Naiki-Ito; Keitaro Iida; Toshiki Etani; Hiroyuki Kato; Shugo Suzuki; Yoriko Yamashita; Noriyasu Kawai; Takahiro Yasui; Satoru Takahashi
Journal:  Oncotarget       Date:  2018-03-23

5.  The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.

Authors:  Roxan F C P A Helderman; Daan R Löke; Jan Verhoeff; Hans M Rodermond; Gregor G W van Bochove; Menno Boon; Sanne van Kesteren; Juan J Garcia Vallejo; H Petra Kok; Pieter J Tanis; Nicolaas A P Franken; Johannes Crezee; Arlene L Oei
Journal:  Cells       Date:  2020-07-25       Impact factor: 6.600

6.  Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder.

Authors:  Nathalie van den Tempel; Kishan A T Naipal; Anja Raams; Dik C van Gent; Martine Franckena; Joost L Boormans; Roland Kanaar
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

7.  Significance of TP53 mutation in bladder cancer disease progression and drug selection.

Authors:  Guang Wu; Fei Wang; Kai Li; Shugen Li; Chunchun Zhao; Caibin Fan; Jianqing Wang
Journal:  PeerJ       Date:  2019-12-16       Impact factor: 2.984

8.  A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats.

Authors:  Daan R Löke; Roxan F C P A Helderman; Jan Sijbrands; Hans M Rodermond; Pieter J Tanis; Nicolaas A P Franken; Arlene L Oei; H Petra Kok; Johannes Crezee
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

9.  The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis.

Authors:  Antoine G van der Heijden; Christina A Hulsbergen-Van de Kaa; J Alfred Witjes
Journal:  World J Urol       Date:  2007-02-14       Impact factor: 4.226

Review 10.  Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.

Authors:  Arlene L Oei; Lianne E M Vriend; Johannes Crezee; Nicolaas A P Franken; Przemek M Krawczyk
Journal:  Radiat Oncol       Date:  2015-08-07       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.